A novel preoperative risk score to optimize patient selection for performing concomitant liver resection with cytoreductive surgery/HIPEC-Reference-Cited by-同舟云学术

A novel preoperative risk score to optimize patient selection for performing concomitant liver resection with cytoreductive surgery/HIPEC

Published:2020-10 Issue:1 Volume:123 Page:187-195
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J Surg Oncol

Author:

Lee Rachel M.¹²,Gamboa Adriana C.¹²,Turgeon Michael K.¹²,Zaidi Mohammad Y.²³,Kimbrough Charles²⁴,Leiting Jennifer²⁵^ORCID,Grotz Travis²⁶^ORCID,Lee Andrew J.²⁷,Fournier Keith²⁶,Powers Benjamin²⁸⁹^ORCID,Dineen Sean²⁸⁹,Baumgartner Joel M.²¹⁰,Veerapong Jula²¹⁰,Mogal Harveshp²¹¹^ORCID,Clarke Callisia²¹¹^ORCID,Wilson Gregory²¹²,Patel Sameer²¹²^ORCID,Hendrix Ryan²¹³^ORCID,Lambert Laura²¹⁴,Pokrzywa Courtney²¹⁵,Abbott Daniel E.²¹⁵,LaRocca Christopher J.²¹⁶,Raoof Mustafa²¹⁶^ORCID,Greer Jonathan²,Johnston Fabian M.²¹⁷,Staley Charles A.¹²,Cloyd Jordan M.²⁴,Maithel Shishir K.¹²,Russell Maria C.¹²

Affiliation:

1. Department of Surgery, Division of Surgical Oncology Winship Cancer Institute, Emory University Atlanta Georgia USA

2. Department of Surgery, Division of Surgical Oncology University of Minnesota Minneapolis Minnesota USA

3. Department of Surgery Indiana University Indianapolis Indiana USA

4. Department of Surgery, Division of Surgical Oncology The Ohio State University Wexner Medical Center Columbus Ohio USA

5. Division of Hepatobiliary and Pancreas Surgery Mayo Clinic Rochester Minnesota USA

6. Department of Surgery, Division of Gastrointestinal Surgical Oncology University of Pittsburgh Medical Center Pittsburgh Pennsylvania USA

7. Department of Surgical Oncology University of Texas MD Anderson Cancer Center Houston Texas USA

8. Department of Gastrointestinal Oncology Moffitt Cancer Center Tampa Florida USA

9. Department of Oncologic Sciences Morsani College of Medicine Tampa Florida USA

10. Department of Surgery, Division of Surgical Oncology University of California San Diego California USA

11. Department of Surgery, Division of Surgical Oncology Medical College of Wisconsin Milwaukee Wisconsin USA

12. Department of Surgery University of Cincinnati College of Medicine Cincinnati Ohio USA

13. Department of Surgical Oncology, Health Huntsman Cancer Institute University of Utah Salt Lake City Utah USA

14. Department of Surgery, Division of Surgical Oncology University of Massachusetts Medical School Worcester Massachusetts USA

15. Department of Surgery, Division of Surgical Oncology University of Wisconsin Madison Wisconsin USA

16. Department of Surgery, Division of Surgical Oncology Johns Hopkins University Baltimore Maryland USA

17. Department of Surgery Johns Hopkins University Baltimore Maryland USA

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jso.26239

Reference19 articles.

1. Synchronous liver resection with cytoreductive surgery for the treatment of liver and peritoneal metastases from colon cancer: results from an Australian centre

2. Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies

3. Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer;Elias D;Eur J Cancer Surg,2006

4. Surgical Treatment of Colorectal Cancer with Peritoneal and Liver Metastases Using Combined Liver and Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Report from a Single-Centre Experience

5. Impact of Synchronous Liver Resection on the Perioperative Outcomes of Patients Undergoing CRS-HIPEC

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A machine learning approach for predicting textbook outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy;World Journal of Surgery;2024-04-23

2. Synchronous liver and peritoneal metastases from colorectal cancer: Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy combined with liver resection a feasible option?;Frontiers in Surgery;2022-12-15

3. Is Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy Still Indicated in Patients With Extraperitoneal Disease?;Journal of Surgical Research;2022-09

4. Outcomes of Combined Peritoneal and Local Treatment for Patients with Peritoneal and Limited Liver Metastases of Colorectal Origin: A Systematic Review and Meta-Analysis;Annals of Surgical Oncology;2021-10-22

5. Definition and Prediction of Early Recurrence and Mortality Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: Towards Predicting Oncologic Futility Preoperatively;Annals of Surgical Oncology;2021-07-05